Title:
MOUSE ANTI-MCR-1 PROTEIN HYBRIDOMA CELL STRAIN, MONOCLONAL ANTIBODY, AND APPLICATION
Document Type and Number:
WIPO Patent Application WO/2023/024313
Kind Code:
A1
Abstract:
The present invention provides a mouse anti-MCR-1 protein hybridoma cell strain, a monoclonal antibody produced thereby, and an application. The mouse anti-MCR-1 protein antibody is suitable for being used as an immunodiagnostic reagent for in vitro diagnosis of an MCR-1 protein antigen.
Inventors:
XIA BIN (CN)
HE YONGSHENG (CN)
LI KEKE (CN)
CHEN XIAOLING (CN)
YUAN QINGHUA (CN)
WANG YAMIAO (CN)
KONG DI (CN)
WANG SIYI (CN)
HE YONGSHENG (CN)
LI KEKE (CN)
CHEN XIAOLING (CN)
YUAN QINGHUA (CN)
WANG YAMIAO (CN)
KONG DI (CN)
WANG SIYI (CN)
Application Number:
PCT/CN2021/135407
Publication Date:
March 02, 2023
Filing Date:
December 03, 2021
Export Citation:
Assignee:
TIANJIN ERA BIOLOGY TECH CO LTD (CN)
International Classes:
C12N5/20; C07K16/28; C12N15/13; G01N33/577; G01N33/58; G01N33/74
Domestic Patent References:
WO2019204496A1 | 2019-10-24 | |||
WO2018158573A1 | 2018-09-07 |
Foreign References:
CN113416710A | 2021-09-21 | |||
US20190322727A1 | 2019-10-24 | |||
CN111487417A | 2020-08-04 |
Attorney, Agent or Firm:
NUODE IP LAW FIRM (CN)
Download PDF:
Previous Patent: GALVANIC REPLACEMENT REACTION-BASED SERS ENHANCED SUBSTRATE PREPARATION METHOD
Next Patent: TANTALUM LINING STRUCTURE OF APPARATUS
Next Patent: TANTALUM LINING STRUCTURE OF APPARATUS